// App-Quantinova.ai

126 : Clinical outcomes at two years of the Absorb BRS vs. the Xience metallic DES in patients presenting with ACS vs. stable coronary disease - AIDA trial substudy

Researchers

Presenter

  • R Y G Tijssen

Principal Investigators

  • RJ Van Der Schaaf

  • MA Vink

  • RP Kraak

  • SH Hofma

  • EK Arkenbout

  • APJD Weevers

  • LS Kerkmeijer

  • Y Onuma

  • PWJC Serruys

  • JJ Piek

  • JGP Tijssen

  • JP Henriques

  • RJ De Winter

  • JJ Wykrzykowska

Medical Centers

  • Academic Medical Center, Amsterdam, Netherlands

  • Hospital Onze Lieve Vrouwe Gasthuis

  • Medical Center Leeuwarden

  • Tergooi Hospital

  • Albert Schweitzer Hospital, Dordrecht, Netherlands

  • Erasmus University Medical Center, Rotterdam, Netherlands

  • University College London - London - United Kingdom of Great Britain & Northern Ireland

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Acute Coronary Syndromes

  • Coronary Artery Disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Everolimus

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved